Literature DB >> 9877527

Huntington disease: clinical, genetic, and social aspects.

M A Nance1.   

Abstract

Huntington disease (HD) is a fascinating neurodegenerative disorder whose features straddle the boundaries of psychiatry, neurology, and genetics. The clinical symptoms of HD consist of a triad of motor, cognitive, and psychiatric/behavioral disturbances. In 1993, the HD Collaborative Research Group identified the gene and the mutation responsible for HD. HD was one of the first neurodegenerative disorders discovered to be caused by a novel mutational mechanism known as trinucleotide repeat expansion. Since then, HD has been the model for autosomal dominant neurogenetic disorders. The clinical, pathological, and genetic aspects of the disease are reviewed and some of the questions that remain to be answered by researchers of the 21st century are outlined.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9877527     DOI: 10.1177/089198879801100204

Source DB:  PubMed          Journal:  J Geriatr Psychiatry Neurol        ISSN: 0891-9887            Impact factor:   2.680


  9 in total

1.  Modeling Huntington's disease in cells, flies, and mice.

Authors:  S Sipione; E Cattaneo
Journal:  Mol Neurobiol       Date:  2001-02       Impact factor: 5.590

2.  Neurochemical changes in Huntington R6/2 mouse striatum detected by in vivo 1H NMR spectroscopy.

Authors:  Ivan Tkac; Janet M Dubinsky; C Dirk Keene; Rolf Gruetter; Walter C Low
Journal:  J Neurochem       Date:  2007-01-08       Impact factor: 5.372

3.  Differential susceptibility of striatal, hippocampal and cortical neurons to Caspase-6.

Authors:  Anastasia Noël; Libin Zhou; Bénédicte Foveau; P Jesper Sjöström; Andréa C LeBlanc
Journal:  Cell Death Differ       Date:  2018-01-19       Impact factor: 15.828

4.  Understanding the need for assistance with survey completion in people with Huntington disease.

Authors:  Elizabeth A Hahn; Nancy R Downing; Julie C Stout; Jane S Paulsen; Becky Ready; Siera Goodnight; Jin-Shei Lai; Jennifer A Miner; Noelle E Carlozzi
Journal:  Qual Life Res       Date:  2017-12-06       Impact factor: 4.147

5.  Excessive blinking as an initial manifestation of juvenile Huntington's disease.

Authors:  Shihui Xing; Ling Chen; Xi Chen; Zhong Pei; Jinsheng Zeng; Jinru Li
Journal:  Neurol Sci       Date:  2008-09-20       Impact factor: 3.307

6.  Ablation of D1 dopamine receptor-expressing cells generates mice with seizures, dystonia, hyperactivity, and impaired oral behavior.

Authors:  Ilse Gantois; Ke Fang; Luning Jiang; Daniela Babovic; Andrew J Lawrence; Vincenzo Ferreri; Yaroslav Teper; Bianca Jupp; Jenna Ziebell; Cristina M Morganti-Kossmann; Terence J O'Brien; Rachel Nally; Günter Schütz; John Waddington; Gary F Egan; John Drago
Journal:  Proc Natl Acad Sci U S A       Date:  2007-02-28       Impact factor: 11.205

7.  Motor speech patterns in Huntington disease.

Authors:  Sarah K Diehl; Antje S Mefferd; Ya-Chen Lin; Jessie Sellers; Katherine E McDonell; Michael de Riesthal; Daniel O Claassen
Journal:  Neurology       Date:  2019-10-29       Impact factor: 9.910

8.  The Huntington's Disease health-related Quality of Life questionnaire (HDQoL): a disease-specific measure of health-related quality of life.

Authors:  M B Hocaoglu; E A Gaffan; A K Ho
Journal:  Clin Genet       Date:  2012-02       Impact factor: 4.438

9.  Longitudinal study revealing motor, cognitive and behavioral decline in a transgenic minipig model of Huntington's disease.

Authors:  Monika Baxa; Bozena Levinska; Monika Skrivankova; Matous Pokorny; Jana Juhasova; Jiri Klima; Jiri Klempir; Jan Motlı K; Stefan Juhas; Zdenka Ellederova
Journal:  Dis Model Mech       Date:  2019-12-12       Impact factor: 5.758

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.